The present invention involves a novel neuroendocrine growth factor or marker ("NEM") identified in cultured prostate cancer cells and conjugates of NEM and a binding agent capable of inhibiting binding of NEM to its receptor.

 
Web www.patentalert.com

< Hepatitis B virus surface protein

< Methods and compositions for treatment of central nervous system disorders

> Method of using metaloporphyrins for treatment of arteriosclerotic lesions

> Nucleic acid encoding pigment protein from coral tissue
~ 00251